Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) is on a mission to bring jobs back to the United States while commercializing stored energy solutions that meet the stringent quality standards necessary to power state-of-the-art technologies in a variety of expansive and growing industries. The company’s innovative ‘Made in the USA’ product line already includes multiple […]

Back in 2001, Ms. Gay, a frail 85-year-old, was out walking her dog, Blue, in Florida. She slipped and, falling to the ground, couldn’t get up. It wasn’t long before her plight was noticed by a ‘gator. Alligators in Florida typically measure over eight feet and weigh about 800 lbs. The only thing standing between […]

A pioneer in developing digital commerce technologies, Alternet Systems, Inc. (OTCQB: ALYI) aims to transform the electronic payment infrastructure that is so popular today. The company sees a bright future of global access to efficient and affordable banking and payment services. To align itself with this ever-increasing trend, Alternet Systems continues to develop advanced predictive […]

The recent announcement by Avant Diagnostics, Inc (OTCQB: AVDX) and Amarantus Bioscience Holdings, Inc (OTCQX: AMBS) of their intention to tie the knot is a message of cheer for women who may be at risk for ovarian cancer. It also promises a partnership that will aggressively pursue opportunities in the rapidly expanding molecular diagnostics (MDx) […]

Before the opening bell, Nutra Pharma Corporation (OTCQB: NPHC) announced that it will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference, which will take place at The Ritz-Carlton in Miami on South Beach on February 22, 2016. As a presenter, Nutra Pharma will be provided with a 30-minute time slot […]

On Wednesday, leading independent equity research and corporate access firm SeeThruEquity announced that it has initiated coverage on Immune Therapeutics, Inc. (OTCQB: IMUN) with a 12-month price target of $0.61. IMUN is a specialty pharmaceutical company engaged in the manufacture, distribution and marketing of proprietary therapies targeting chronic, life-threatening diseases through the activation of the […]

According to the American Pet Products Association’s 2015-2016 National Survey (http://dtn.fm/0hCVP), there are roughly 86 million pet cats in the United States, up from about 21.5 million in 1970. Across the nearly 43 million American households that currently own a pet cat, one seemingly nondescript product has become virtually ubiquitous – cat litter. Cat litter […]

Short interest in OurPet’s Company (OTCQX: OPCO) has sharply fallen, presumably driven by a host of factors, including word that the specialty pet retailer has several new pet products and strategies on deck. The company’s total short interest was 1,900 shares in February, as reported by FDANewsAlert.com (citing FINRA), a drop of 70.7% from 6,500 […]

Parkinson’s disease is caused by death of dopamine-producing cells in a brain region called the substantia nigra, which hampers movement. Current treatments focus primarily on replacing the lost dopamine, but these treatments eventually fail because the dopamine-making cells continue to die. For this reason, stem cell therapy is of interest. International Stem Cell Corporation (OTCQB: […]

GTX Corp. (OTC: GTXO) stands at the forefront of wearable GPS technology while being a leader in two-way personal location services. Headquartered in Los Angeles, the company shows off its knowledge of miniaturized and low-power consumption GPS, BLE, and cellular tracking solutions. GTXO has distributors in 13 countries that send-off customizable solutions like hardware, apps, […]